Cargando…
Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
OBJECTIVE: Thiazolidinediones and insulin are associated with a higher risk of fractures in type 2 diabetic patients. Incretin hormones increase bone density in experimental models, but the effect of dipeptidyl peptidase-4 (DPP-4) inhibitors on bone fractures has not been reported so far. RESEARCH D...
Autores principales: | Monami, Matteo, Dicembrini, Ilaria, Antenore, Alessandro, Mannucci, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198283/ https://www.ncbi.nlm.nih.gov/pubmed/22025784 http://dx.doi.org/10.2337/dc11-1099 |
Ejemplares similares
-
Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
por: Monami, Matteo, et al.
Publicado: (2008) -
Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus
por: Bigagli, Elisabetta, et al.
Publicado: (2020) -
Dipeptidyl peptidase‐4 inhibitors and prevention of bone fractures: Effects beyond glyemic control
por: Yabe, Daisuke, et al.
Publicado: (2012) -
Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
por: Giugliano, Dario, et al.
Publicado: (2011) -
Meta-Analysis of the Significance of Asymptomatic Bacteriuria in Diabetes
por: Renko, Marjo, et al.
Publicado: (2011)